Literature DB >> 22226117

Clinical trials In BMT: ensuring that rare diseases and rarer therapies are well done.

Susan Shurin1, Jeff Krischer, Stephen C Groft.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22226117      PMCID： PMC6501792          DOI： 10.1016/j.bbmt.2011.10.030

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  5 in total

Review 1.  Good-quality research in rare diseases: trials and tribulations.

Authors:  Davide Bolignano; Anna Pisano
Journal:  Pediatr Nephrol       Date:  2016-01-27       Impact factor: 3.714

2.  Emerging Genetic Counselor Roles within the Biotechnology and Pharmaceutical Industries: as Industry Interest Grows in Rare Genetic Disorders, How are Genetic Counselors Joining the Discussion?

Authors:  Tessa Field; Stephanie Jo Brewster; Meghan Towne; MaryAnn W Campion
Journal:  J Genet Couns       Date:  2016-03-28       Impact factor: 2.537

Review 3.  Innovative research methods for studying treatments for rare diseases: methodological review.

Authors:  Joshua J Gagne; Lauren Thompson; Kelly O'Keefe; Aaron S Kesselheim
Journal:  BMJ       Date:  2014-11-24

4.  Accrual-Monitoring Practices for Various Disease Trials among AACI Member Cancer Centers.

Authors:  Zachary T Elliott; Zachary Goldberg; Ramez Philips; Jennifer M Johnson; Margaret T Kasner; William K Kelly; Sarah Osipowicz; Rachael Dampman; Joseph M Curry
Journal:  Clin Pract       Date:  2022-08-31

5.  Changing the Paradigm for the Treatment and Development of New Therapies for FSGS.

Authors:  Cathie Spino; Jordan S Jahnke; David T Selewski; Susan Massengill; Jonathan Troost; Debbie S Gipson
Journal:  Front Pediatr       Date:  2016-03-23       Impact factor: 3.418
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.